Infections in continuous ambulatory peritoneal dialysis

References

1. Ash S. R. 1984; Biocompatibility and hydraulic function of Tenckhoff and Lifecath catheters. Peritoneal Dialysis Bulletin 4: Suppl S103–S106
   [Google Scholar]
2. Buggy B. P., Schaberg D. R., Swartz R. D. 1984; Intraleukocytic sequestration as a cause of persistent Staphylococcus aureus peritonitis in continuous ambulatory peritoneal dialysis. American Journal of Medicine 16:1035–1040
   [Google Scholar]
3. Christensen G. D., Parisi J. T., Bisno A. L., Simpson W. A., Beachey E. H. 1983; Characterization of clinically significant strains of coagulase-negative staphylococci. Journal of Clinical Microbiology 18:258–269
   [Google Scholar]
4. Clarke L. A., Easmon C. S. F. 1986; Opsonic activity of intravenous immunoglobulin preparation against Staphylococcus epidermidis. Journal of Clinical Pathology 39:856–860
   [Google Scholar]
5. Dayman M. D., Raymond A., Colen D., Moffit C., Wolf C., Neilson E. G. 1987; The Limulus amebocyte lysate assay. A rapid and sensitive method for diagnosing early gram-negative peritonitis in patients undergoing continuous ambulatory peritoneal dialysis. Archives of Internal Medicine 147:337–340
   [Google Scholar]
6. Cohen L., Bailey D. 1984; Efficacy of intraperitoneal clindamycin in refractory peritonitis-report of two cases. Peritoneal—Dialysis Bulletin 4:92–94
   [Google Scholar]
7. Craddock C. F., Edwards R., Finch R. G. 1987; Pseudomonas peritonitis in continuous ambulatory peritoneal dialysis: laboratory predictors of treatment failure. Journal of Hospital Infection 10:179–186
   [Google Scholar]
8. Dabbs D. J. W., Davies S., Spencer R. C. 1987; Laboratory diagnosis of peritonitis in CAPD. Lancet 2:334–335
   [Google Scholar]
9. Davenport D. S., Massanari R. M., Pfaller M. A., Bale M. J., Streed S. A., Heirholzer W. J. 1986; Usefulness of a test for slime production as a marker for clinically significant infections with coagulase-negative staphylococci. The Journal of Infectious Diseases 153:332–339
   [Google Scholar]
10. Dawson M. S., Harford A. M., Garner B. K., Sica D. A., Landwehr D. M., Dalton H. P. 1985; Total volume culture technique for the isolation of micro-organisms from continuous ambulatory peritoneal dialysis patients with peritonitis. Journal of Clinical Microbiology 22:391–394
    [Google Scholar]
11. Dunne W. M., Franson T. R. 1986; Coagulase negative staphylococci: the Rodney Dangerfield of pathogens. Clinical Microbiology Newsletter 8:37–42
    [Google Scholar]
12. Eisenberg E. S., Leviton I., Soeiro R. 1986; Fungal peritonitis in patients receiving peritoneal dialysis: experience with 11 patients and review of the literature. Reviews of Infectious Diseases 8:309–321
    [Google Scholar]
13. Eisenberg E. S., Ambalu M., Szylagi G., Aning V., Soeiro R. 1987; Colonization of skin and development of peritonitis due to coagulase-negative staphylococci in patients undergoing peritoneal dialysis. Journal of Infectious Diseases 156:478–482
    [Google Scholar]
14. Evans R. C., Holmes C. J. 1987; Effect of vancomycin hydrochloride on Staphylococcus epidermidis biofilm associated with silicone elastomer. Antimicrobial Agents and Chemotherapy 31:889–894
    [Google Scholar]
15. Fenton P. 1982; Laboratory diagnosis of peritonitis in patients undergoing continuous ambulatory peritoneal dialysis. Journal of Clinical Pathology 35:1181–1184
    [Google Scholar]
16. Fenton S. S. A. 1985; The reduction in the peritonitis rate among high-risk CAPD patients with the use of the Oreopoulos-Zellerman connector. Transactions of the American Society of Artificial Internal Organs 31:560–564
    [Google Scholar]
17. Fleming L. W., Moreland T. A., Scott A. C., Stewart W. K., White L. O. 1987; Ciprofloxacin in plasma and peritoneal dialysate after oral therapy in patients on continuous ambulatory peritoneal dialysis. Journal of Antimicrobial Chemotherapy 19:493–503
    [Google Scholar]
18. Ganter G. 1923; Uber die Beseitigung giftiger Stoffe aus dem Blute durch Dialyse. Munchener Medizinische Wochenschrift 70:1478–1480
    [Google Scholar]
19. Gokal R. 1986; World wide experience, cost effectiveness and future of CAPD—its role in renal replacement therapy. In Gokal R. (ed) Continuous ambulatory peritoneal dialysis Churchill Livingstone; Edinburgh: pp 349–369
    [Google Scholar]
20. Gokal R., Ramos J. M., Ward M. K., Kerr D. N. S. 1981; Eosinophilic peritonitis in continuous ambulatory peritoneal dialysis (CAPD). Clinical Nephrology 15:328–330
    [Google Scholar]
21. Gruer L. D., Bartlett R., Ayliffe G. A. J. 1984; Species identification and antibiotic sensitivity of coagulase-negative staphylococci from CAPD peritonitis. Journal of Antimicrobial Chemotherapy 13:577–583
    [Google Scholar]
22. Harvey D. M., Sheppard K. J., Morgan A. G., Fletcher J. 1987; Effect of dialysate fluids on phagocytosis and killing by normal neutrophils. Journal of Clinical Microbiology 25:1424–1427
    [Google Scholar]
23. Holmes C. J., Evans R. 1986; Biofilm and foreign body infection-the significance to CAPD-associated peritonitis. Peritoneal Dialysis Bulletin 6:168–177
    [Google Scholar]
24. Horsman G. B., MacMillan L., Amatnieks Y., Rifkin O., Vas S. I. 1986; Plasmid profile and slime analysis of coagulase-negative staphylococci from CAPD patients with peritonitis. Peritoneal Dialysis Bulletin 6:195–198
    [Google Scholar]
25. Johnson G. M., Lee D. A., Regelmann W. E., Gray E. D., Peters G., Quie P. G. 1986; Interference with granulocyte function by Staphylococcus epidermidis slime. Infection and Immunity 54:13–20
    [Google Scholar]
26. Junor B. J. R., Briggs J. D., Forwell M. A., Dobbie J. W., Henderson I. 1985; Sclerosing peritonitis-the contribution of chlorhexidine in alcohol. Peritoneal Dialysis Bulletins101–104
    [Google Scholar]
27. Keane W. F., Peterson P. K. 1984; Host defence mechanisms of the peritoneal cavity and continuous ambulatory peritoneal dialysis. Peritoneal Dialysis Bulletin 4:122–127
    [Google Scholar]
28. Keane W. F., Everett E. D., Fine R. N., Golper T. A., Vas S. I., Petersen P. K. 1987; CAPD related peritonitis management and antibiotic therapy recommendations. Peritoneal Dialysis Bulletin 7:56–68
    [Google Scholar]
29. Knight K. R., Polak A., Crump J., Maskell R. 1982; Laboratory diagnosis and oral treatment of CAPD peritonitis. Lancet 2:1301–1304
    [Google Scholar]
30. Kristinsson K. G., Spencer R. C., Brown C. B. 1986a; Clinical importance of production of slime by coagulase-negative staphylococci in chronic ambulatory peritoneal dialysis. Journal of Clinical Pathology 39:117–118
    [Google Scholar]
31. Kristinsson K. G., Spencer R. C., Brown C. B. 1986b; Campylobacter peritonitis in continuous ambulatory peritoneal dialysis. Journal of Infection 13:199–200
    [Google Scholar]
32. Kristinsson K. G., Hastings J. G. M., Oxley K. M., Spencer R. C. 1987; Studies of the pathogenesis of coagulase-negative staphylococcal infections using chemiluminescence and bioluminescence. In Scholmerich. (eds) Bioluminescence and chemiluminescence, new perspectives John Wiley; Chichester: pp 177–180
    [Google Scholar]
33. Krothapalli R. 1982; Pseudomonas peritonitis and continuous ambulatory peritoneal dialysis. Archives of Internal Medicine 142:1862–1863
    [Google Scholar]
34. MacD.Agar J., Flett P. 1984; C-reactive protein-marker of CAPD peritonitis. Peritoneal Dialysis Bulletin A181–182
    [Google Scholar]
35. Males B. M., Walshe J. J., Garringer L., Koscinski D., Amsterdam D. 1986; Addi-chek filtration, BACTEC, and 10-ml culture methods for recovery of micro-organisms from dialysis effluent during episodes of peritonitis. Journal of Clinical Microbiology 23:350–353
    [Google Scholar]
36. Neville L. O., Baillod R., Miller J. M. T., Brumfitt W. 1987; CAPD Peritonitis. Lancet 1:1320
    [Google Scholar]
37. Oreopoulos D. G., Vas S. I., Khanna R. 1983; Prevention of peritonitis during continuous ambulatory peritoneal dialysis. Peritoneal Dialysis Bulletin 3: Suppl S18–S20
    [Google Scholar]
38. Pascual A., Fleer A., Westerdaal N. A. C., Verhoef J. 1986; Modulation of adherence of coagulase-negative staphylococci to teflon catheters in vitro. European Journal of Clinical Microbiology 5:518–522
    [Google Scholar]
39. Peters G., Pulverer G. 1984; Pathogenesis and management of Staphylococcus epidermidis “plastic” foreign body infections. Journal of Antimicrobial Chemotherapy 14: Suppl D67–71
    [Google Scholar]
40. Peters G., Locci R., Pulverer G. 1982; Adherence and growth of coagulase-negative staphylococci on surfaces of intravenous catheters. Journal of Infectious Diseases 146:479–482
    [Google Scholar]
41. Peterson P. K., Matzke G., Keane W. F. 1987; Current concepts in the management of peritonitis in patients undergoing continuous ambulatory peritoneal dialysis. Reviews of Infectious Diseases 9:604–612
    [Google Scholar]
42. Popovich R. P., Moncrief J. W., Decherd J. F., Bomar J. B., Pyle W. K. 1976; The definition of a novel portable/wearable equilibrium peritoneal dialysis technique. Abstracts of American Society of Artificial Internal Organs 5:64
    [Google Scholar]
43. Schwalbe R. S., Stapleton J. T., Gilligan P. H. 1987; Emergence of vancomycin resistance in coagulase-negative staphylococci. New England Journal of Medicine 316:927–931
    [Google Scholar]
44. Sewell D. L., Golper T. A. 1982; Stability of antimicrobial agents in peritoneal dialysate. Antimicrobial Agents and Chemotherapy 21:528–529
    [Google Scholar]
45. Sheth N. K., Franson T. R., Sohnle P. G. 1985; Influence of bacterial adherence to intravascular catheters on in-vitro antibiotic susceptibility. Lancet 2:1266–1268
    [Google Scholar]
46. Sheth N. K., Bartell C. A., Roth D. A. 1986; In vitro study of bacterial growth in continuous ambulatory peritoneal dialysis fluids. Journal of Clinical Microbiology 23:1096–1098
    [Google Scholar]
47. Spencer R. C., Fenton P. A. 1984; Infective complications of peritoneal dialysis. Journal of Hospital Infection 5:233–240
    [Google Scholar]
48. Spencer R. C., Ahmad W. K. 1986; Laboratory diagnosis of peritonitis in continuous ambulatory peritoneal dialysis by lysis and centrifugation. Journal of Clinical Pathology 39:925–926
    [Google Scholar]
49. Starling E. H., Tubby A. H. 1894; On absorption from and secretion into the serous cavities. Journal of Physiology 16:140–155
    [Google Scholar]
50. Tenckhoff H., Schechter H. 1968; A bacteriologically safe peritoneal access device. Transactions of American Society of Artificial Internal Organs 14:181–187
    [Google Scholar]
51. Verbrugh H. A., Keane W. F., Hoidal J. R., Freiberg M. R., G R., Peterson P. K. 1983; Peritoneal macrophages and opsonins: antibacterial defence in patients undergoing chronic peritoneal dialysis. Journal of Infectious Diseases 147:1018–1029
    [Google Scholar]
52. Verbrugh H. A., Keane W. F., Conroy W. E., Peterson P. K. 1984; Bacterial growth and killing in chronic ambulatory peritoneal dialysis liquid. Journal of Clinical Microbiology 20:199–203
    [Google Scholar]
53. Weissauer-Condon C., Engels I., Daschner F. D. 1987; In vitro activity of four new quinolones in Mueller-Hinton broth and peritoneal dialysis fluid. European Journal of Clinical Microbiology 6:324–326
    [Google Scholar]
54. West T. E., Walshe J. J., Krol C. P., Amsterdam D. 1986; Staphylococcal peritonitis in patients on continuous peritoneal dialysis. Journal of Clinical Microbiology 23:809–812
    [Google Scholar]
55. Wheat P. F., Winstanley T. G., Spencer R. C. 1985; Effect of temperature on antimicrobial susceptibilities of Pseudomonas maltophilia. Journal of Clinical Pathology 38:1055–1058
    [Google Scholar]
56. Working Party of the British Society for Antimicrobial Chemotherapy 1987; Diagnosis and management of peritonitis in continuous ambulatory peritoneal dialysis. Lancet 1:845–849
    [Google Scholar]